LDT Oversight Remains Under CLIA, for Now
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
FDA-lca
Subscribe today for access to
Articles and Reports
FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
MeMed Sepsis Test Gains Breakthrough Device Designation
The 15-minute assay to detect sepsis and assess its severity and risk is expected to get full FDA approval by 2026
FDA’s LDT Oversight Framework Could Impact 60,000+ Tests
...
Already a member? Log in here
FDA’s 2016 Guidance Plans Include LDTs and Other Diagnostics Topics
...
Already a member? Log in here
FDA Workshop Addresses Security of Medical Devices
From - G2 Compliance Advisor
The U.S. Food and Drug Administration (FDA) is joining the cadre of government agencies calling attention to the cybersecurity risks of wireless, internet-and network-connected devices and…
FDA and CMS Address LDT Regulation Before Energy and Commerce Committee
...
Already a member? Log in here
FDA Details Oversight of Medical Applications On Smart Phones and Tablets
...
Already a member? Log in here
Final FDA Guidance on RUO, IUO Products Raises Compliance Concerns for Labs
...
Already a member? Log in here
- « Previous
- 1
- …
- 3
- 4
- 5